Trial site
Neurology Clinic, P.C.
- 14running trials
- 4closed trials
The trials here
What the 18 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease15 trials
- Mild cognitive impairment4 trials
- Multiple sclerosis2 trials
- Parkinson disease1 trial
- Phase
- Phase 310 trials
- Phase 25 trials
- Phase 2/32 trials
- Phase 41 trial
- Status
- Active, not recruiting8 trials
- Recruiting6 trials
- Completed3 trials
- Terminated1 trial
- Lead sponsor
- Eli Lilly and Company4 trials
- Annovis Bio Inc.2 trials
- Eisai Inc.2 trials
- Zenas BioPharma (USA), LLC2 trials
- Acumen Pharmaceuticals1 trial
- and 7 more
Running trials
Recruiting
Recruiting
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Recruiting
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD
Active, not recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
Active, not recruiting
A Study of E2814 With Concurrent Lecanemab Treatment in Participants With Early Alzheimer's Disease
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Active, not recruiting
A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease3 recruiting
- Multiple sclerosis2 recruiting
- Parkinson disease1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026